[Dilated cardiomyopathyDilated Cardiomyopathy Associated with HIV Infection associated with HIV infection]

Area of Science:

• Cardiology
• Infectious Diseases
• Internal Medicine

Background:

• Dilated cardiomyopathy (DCM) is a potential cardiac complication in patients with human immunodeficiency virus (HIV) infection.
• Understanding the specific mechanisms and clinical course of DCM in the context of HIV is crucial for patient management.

Purpose of the Study:

• To present a case of dilated cardiomyopathy development in an HIV-infected patient.
• To describe the outcomes of four years of dynamic monitoring and therapeutic interventions.
• To review current literature on DCM in HIV infection, including pathogenesis, clinical features, and treatment strategies.

Main Methods:

• Case report presentation.
• Dynamic patient monitoring over a four-year period.
• Administration of cardiotropic and antiretroviral therapies.
• Literature review and data synthesis.

Main Results:

• Successful management of dilated cardiomyopathy in an HIV-infected patient over four years.
• Demonstration of the feasibility of combined cardiotropic and antiretroviral therapy.
• Insights into the frequency, pathogenesis, and clinical course of DCM in HIV.

Conclusions:

• Dilated cardiomyopathy is a significant concern in HIV infection, requiring vigilant monitoring.
• Integrated therapeutic approaches combining cardiac support and antiretroviral therapy are effective.
• Further research into the specific pathogenetic links between HIV and DCM is warranted.